Share Issue/Capital Change • Jan 7, 2021
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 9244K
Spire Healthcare Group PLC
07 January 2021
Spire Healthcare Group plc
(the Company)
Block Listing application of Ordinary Shares
Application has been made to the UK Listing Authority and the London Stock Exchange plc for a block listing of 4,000,000 ordinary shares of 1 pence each in the Company (the Shares) to be admitted to the Official List and to trading on the London Stock Exchange plc. It is anticipated that the Shares will be admitted on 11 January 2021.
The Shares are being reserved under a block listing and will be issued in connection with the grant, vesting and/or exercise of awards under the terms of the following employee share scheme:
| Scheme name | Amount of shares |
| Spire Healthcare Group plc SAYE option scheme 2016 (Sharesave) | 4,000,000 |
When issued, the Shares will rank pari passu in all respects with the existing issued ordinary shares of the Company.
For further information, please contact:
Spire Healthcare Group plc
Philip Davies
Company Secretary
Tel: +44 (0) 207 427 9092
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ALSBDLFBFFLEBBZ
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.